Advertise on podcast: The Long Run with Luke Timmerman

Rating

★★★★★

4.7

from

127 reviews

Description

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Unlock The Long Run with Luke Timmerman podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from The Long Run with Luke Timmerman podcast

Ep211: Ardem Patapoutian on Touch, Pain & New Discoveries in Neuroscience

2026/10/07

Arden Patapoutian, professor of neuroscience at Scripps Research and Howard Hughes Medical Institute, on new discoveries in neuroscience related to our sense of touch, pain, and more.

Ep210: Cameron Turtle on Long-Lasting Antibodies for Immune Disorders

2026/09/23

Cameron Turtle, CEO of Waltham, Mass.-based Spyre Therapeutics, on developing long-lasting antibodies for immune disorders.

Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets

2026/09/09

Mathai Mammen, CEO of Cambridge, Mass.-based Parabilis Medicine, on developing alpha helical peptide molecules against hard targets of disease.

Ep208: Gary Nabel on Developing a Vaccine for Epstein-Barr Virus

2026/08/25

Gary Nabel, CEO of Weston, Mass.-based ModeX Therapeutics, on developing a vaccine for Epstein-Barr Virus.

Ep207: Jason Coloma on Genetic Medicines for Kidney Diseases

2026/08/11

Jason Coloma, CEO of South San Francisco-based Maze Therapeutics, on developing small molecule drugs based on human genetics for kidney diseases.

Ep206: Lyn Baranowski on Inhalable Medicines for Severe Lung Diseases

2026/07/28

Lyn Baranowski, CEO of Boston-based Avalyn Pharma, on developing inhalable medicines for severe lung diseases.

Ep205: Heather Turner on a Schizophrenia Drug Patients Can Stick With

2026/07/14

Heather Turner, CEO of New York-based LB Pharma, on developing a new schizophrenia drug designed to better cross the blood-brain barrier, be dosed once daily, and make it easier for patients to take long term.

Ep204: Troy Wilson on Precision Cancer Drugs and Combos

2026/06/30

Troy Wilson, CEO of San Diego-based Kura Oncology, on his career in biotech and developing targeted cancer drugs.

Ep203: Sri Kosuri on Small Molecule Correctors of Disease

2026/06/16

Sri Kosuri, co-founder and CEO of Emeryville, Calif.-based Octant Bio, on small molecules designed to correct protein misfolding and mistrafficking at the root of many diseases.

Ep202: Becky Pferdehirt on Reimagining Science for the AI Era

2026/06/02

Becky Pferdehirt, CEO of Emeryville, CA-based Radial, the life sciences unit of Astera Institute, on reimagining biology to take advantage of advances in AI.

Ep201: Jeremy Levin on Biotech in the Balance

2026/05/19

Jeremy Levin, executive chair of Ovid Therapeutics, discusses his new book "Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust."

Ep200: Richard Pops Reflects on a 35-Year Career in Biotech

2026/05/05

Alkermes CEO Richard Pops reflects on his 35-year career leading the company and its new opportunity in orexin biology for sleep disorders and more neurological conditions.

Ep199: Martin Burke on Making Small Molecule Medicines for the AI Era

2026/04/21

Marty Burke, a professor of chemistry at the University of Illinois and co-founder of Excelsior Sciences, on making small molecule synthesis more automated for AI.

Ep198: Abbas Kazimi on Computation and Culture for Drug Discovery

2026/04/07

Abbas Kazimi, CEO of Boston-based Nimbus Therapeutics, on computation and culture for drug discovery.

Ep197: Viswa Colluru on Discovering Drugs Inspired by Mother Nature

2026/03/31

Viswa Colluru, founder and CEO of Boulder, Colo.-based Enveda, on drug discovery with a chemistry platform inspired by natural products.

Podcast reviews

Read The Long Run with Luke Timmerman podcast reviews

4.7 out of 5

127 reviews

★★★★★

Lauren Esmay 2024/08/02

Staying Up-to-Date with Timmerman

I have an alert set for each episode drop. As someone who writes for biotech companies, I enjoy listening to each guest detail their company, mission,...

★★★★★

ladyscientistpodcast 2024/02/13

Loved the last 2 episodes!

Discussions around gene regulation with Rick Young and finding your purpose with Robert Ang really stood out to me. Thanks for sharing such great stor...

★★★★★

JPG1618 2020/05/22

A treat while social distancing

During these unusual times, I have found the human stories behind the long run and the great people in our industry a wonderful treat. I listen while ...

★★★★★

1-2-3 Josh 2020/05/19

Great Podcast

I am someone that is not in the bio tech world, but find it absolutely fascinating. Luke has a great ability as an interviewer to ask questions that m...

★★★☆☆

Oncoproteins 2020/03/28

Let the guests talk more, significantly more

The list of the guests is fantastic. I only wish that the interviewer would let the guests talk and explain things significantly more. I don’t believe...

★★★☆☆

yul51471 2019/12/05

Interesting guests—give them the spotlight

Lots of interesting and unique perspectives here—would suggest that Luke talk/ramble less and focus on the interviewee. At times it feels like Luke im...

★★★★★

DW Howell 2019/08/22

Great Podcast!

I never miss and episode. Would love to see you get one of the Incept founders on. Fred Khosravi and Amar Sawhney have a unique business model and wou...

★★★★☆

BTM12 2019/08/14

Kick it up a notch

Big fan of Luke! But he needs to drink 2 shots of espresso before these interviews and watch a couple mainstream cooking shows to see how to keep audi...

★★★★★

Keermaster 2018/07/24

A needle in the haystack of biotechnology

A great listen for anyone who is going into industry or is an investor in biotech. I would love to see more episodes of deans of biotech grad schools ...

★☆☆☆☆

Neptune from Norfolk 2018/04/30

Episodes 15 and 16

The listener cannot hear guest on episodes 15 and 16.

check all reviews on apple podcasts